A 3.4-kb BamHI fragment that is assumed to be a part of the aklavinone biosynthetic gene cluster of Streptomyces galilaeus 3AR-33 and contains the genes required for the early stage of polyketide biosynthesis was sequenced. The nucleotide sequence of the region that hybridizes to the actIII probe reveals the presence of a gene, aknA, whose deduced protein product is very similar to the Actlll protein and other known oxidoreductases. The predicted AknA protein is believed to be responsible for catalyzing the reduction of the keto group at the ninth carbon from the carboxyl terminus of the assembled polyketide to the corresponding secondary alcohol. The predicted AknA protein has a calculated molecular mass of 27,197 Da (261 amino acids) and the highly conserved sequence Gly-Xaa-Gly-Xaa-Xaa-Ala commonly seen in oxidoreductases. Cloning and sequence analysis of the aknA region of the 2-hydroxyaklavinone-producing strain S. galilaeus ANR-58 identified an alteration in the gene, confirming that the aknA gene is essential for aklavinone biosynthesis.
The mechanism of polyketide chain assembly is closely related to that of fatty acid synthesis. Similar reduction cycles are used for both biosynthetic pathways, with the difference that the reduction cycles after each condensation of a C2 unit are often incomplete in the case of the polyketide synthases (3) . This ,B-ketoreduction step contributes to the structural diversities of the aromatic polyketides. For example, the actIII gene is believed to encode a 3-ketoreductase that reduces the keto group of the assembled polyketide precursor of actinorhodin to the corresponding secondary alcohol (2) .
homologous region of the 3.4-kb BamHI fragment that is believed to determine the reduction of the keto group at the ninth carbon from the carboxyl terminus of the assembled polyketide to the corresponding secondary alcohol. A mutant allele, which causes accumulation of 2-hydroxyaklavinone by S. galilaeus ANR-58 (9, 10), was also sequenced.
Complementation and DNA sequence analysis of the aknA region. The whole cloned 3.4-kb region (as plasmid pAKDllF) restores aklavinone production when introduced into S. galilaeus ANR-58, whereas the 0.8-kb BamHI-SalI fragment that The aclacinomycins (4) , which were isolated in 1975 from Streptomyces galilaeus MA144-Ml, are commercially important anthracycline antibiotics with potent antitumor activity. The S. galilaeus mutant strain 3AR-33 accumulates aklavinone, the aglycone of the aclacinomycins and an important biosynthetic precursor of other anthracycline aglycones (Fig. 1) . We previously reported the cloning of a 3.4-kb BamHI fragment from S. galilaeus 3AR-33 that restores aklavinone synthesis to blocked mutants (7) . Here, we report the DNA sequence of an actIII hybridizes strongly to an actIII probe did not complement the mutant when introduced on pAKD12 (Fig. 2) . Sequencing of the whole BamHI fragment after subcloning from XAKDII1 into pBluescriptll revealed that the relevant Sall site was inside an open reading frame homologous to actIII (Fig. 3) .
The protein coding region for this gene (aknA) is assumed to start at nucleotide (nt) position 63 with an ATG codon, which is preceded by a potential ribosome binding site centered 9 nt further upstream. The coding region ends at nt position 846 with a TGA codon. In an optimal alignment, aknA possessed 67.9% nucleotide sequence identity to the actIII gene, while its deduced product (Mr, 27, 197) Nucleotide sequence accession number. The nucleotide sequence of aknA has been submitted to the DDBJ, EMBL, and GenBank nucleotide sequence data bases with the accession number D14040.
